Drug: LUPRON Injury: Malignant neoplasm progression Quarter: 2016Q3
Total Records: 12 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 109187903 | LUPRON | Malignant neoplasm progression | ASTELLAS | 59.62 YR | M | 0 | 20160915 | US |
| 115031532 | LUPRON | Malignant neoplasm progression | ASTELLAS | 0.00 | M | 0 | 20160915 | US |
| 115033952 | LUPRON | Malignant neoplasm progression | ASTELLAS | 69.98 YR | M | 0 | 20160915 | US |
| 115035836 | LUPRON | Malignant neoplasm progression | ASTELLAS | 74.80 YR | M | 0 | 20160823 | US |
| 122232802 | LUPRON | Malignant neoplasm progression | ASTRAZENECA | 90.00 YR | M | 0 | 20160726 | US |
| 123566463 | LUPRON | Malignant neoplasm progression | ASTRAZENECA | 791.00 MON | M | 0 | 20160817 | US |
| 125739042 | LUPRON | Malignant neoplasm progression | AMGEN | 69.00 YR | M | 0 | 20160808 | US |
| 126437422 | LUPRON | Malignant neoplasm progression | AMGEN | 75.00 YR | M | 0 | 20160929 | US |
| 127505961 | LUPRON | Malignant neoplasm progression | ASTELLAS | 78.93 YR | M | 0 | 20160915 | US |
| 127507001 | LUPRON | Malignant neoplasm progression | ASTELLAS | 77.70 YR | M | 0 | 20160915 | US |
| 127512031 | LUPRON | Malignant neoplasm progression | ASTELLAS | 0.00 | M | 0 | 20160915 | US |
| 127543061 | LUPRON | Malignant neoplasm progression | ASTELLAS | 64.57 YR | M | 0 | 20160915 | US |
Total Records: 12 Number of Pages: 1